2026

A. Medvedeva; H. Teimouri; A.B. Kolomeisky 2026 Oligomerization can enhance synergistic activity of antimicrobial peptides. Molecular Physics (Volume 124, Issue 3-4, SI, 12/29/2024)

2025

M. Batista; P. Murphy; O.A. Igoshin; M. Perepelitsa; I. Timofeyev 2025 Role of non-exponential reversal times in aggregation models of bacterial populations. Mathematical Biosciences (Volume 383)
P. Ahlawat; C. Clementi; F. Musil; M.A. Filip; M.I. Dar 2025 Lattice-Matched Heterogeneous Nucleation Eliminates Defective Buried Interfaces in Halide Perovskites. Chemistry of Materials (Volume 37, Issue 6, Page 2177-2191, 3/12/2025)
P. Kulkarni; L. Porter, L; T.F. Chou; S. Chong; F. Chiti; J.W. Schafer; A. Mohanty; S. Ramisetty; J… 2025 Evolving concepts of the protein universe. IScience (Volume 28, Issue 3, 3/21/2025)
A. Mondal; A.B. Kolomeisky 2025 Why Antiholins? Thermodynamic and Kinetic Arguments to Explain the Robustness of Bacteriophage Cell Lysis. Journal of Physical Chemistry Letters (Volume 16, Issue 11, Page 2920-2926, 3/12/2025)
P. Shrestha; Z.S. Ghoreyshi; J.T. George 2025 How modulation of the tumor microenvironment drives cancer immune escape dynamics. Scientific Reports (Volume 15, Issue 1, 3/10/2025)
K.A. Harrisson; L.B. Beheregaray; C.M. Bice; E.J. Booth; C.J. Brauer; G.L. Butler; D. Dawson, D; O… 2025 Otolith and Genomic Data Reveal Temporal Insights Into Stocking Across a Large River Basin in a Mobile, Long-Lived Australian Freshwater Fish Species. Molecular Ecology (Volume 34, Issue 7, 3/13/2025)
H. Teimouri; Z.S. Ghoreyshi; A.B. Kolomeisky; J.T. George 2025 Feature selection enhances peptide binding predictions for TCR-specific interactions. Frontiers in Immunology (Volume 15)
O.A. Igoshin; A.B. Kolomeisky; D.E. Makarov 2025 Coarse-Graining Chemical Networks by Trimming to Preserve Energy Dissipation. Journal of Physical Chemistry Letters (Volume 16, Issue 5, Pages 1229-1237, 1/25/2025)
J.H. Park; K.H. Jung; D.Y. Jia; S.K. Yang; K.S. Attri; S. Ahn; D. Murthy; T. Samanta; D. Dutta; M.… 2025 Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Reports Medicine (Volume 6, Issue 2)